<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMJ Case Rep</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMJ Case Rep</journal-id>
      <journal-id journal-id-type="hwp">casereports</journal-id>
      <journal-id journal-id-type="publisher-id">bmjcasereports</journal-id>
      <journal-title-group>
        <journal-title>BMJ Case Reports</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1757-790X</issn>
      <publisher>
        <publisher-name>BMJ Publishing Group</publisher-name>
        <publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27793796</article-id>
      <article-id pub-id-type="pmc">5093353</article-id>
      <article-id pub-id-type="publisher-id">bcr-2016-217555</article-id>
      <article-id pub-id-type="doi">10.1136/bcr-2016-217555</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
        <subj-group subj-group-type="case-report-type">
          <subject>Images In&#x2026;</subject>
        </subj-group>
        <subj-group subj-group-type="hwp-journal-coll">
          <subject>1506</subject>
          <subject>1528</subject>
        </subj-group>
        <subj-group subj-group-type="search-fields">
          <subject>Male</subject>
          <subject>51-70 years</subject>
          <subject>Other Asian</subject>
          <subject>Japan</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Diffuse <sup>18</sup>F-fluorodeoxyglucose accumulation in the bone marrow of a patient with haemophagocytic lymphohistiocytosis due to Hodgkin lymphoma</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Harada</surname>
            <given-names>Shu</given-names>
          </name>
          <xref ref-type="aff" rid="af1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shinohara</surname>
            <given-names>Tsutomu</given-names>
          </name>
          <xref ref-type="aff" rid="af2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Naruse</surname>
            <given-names>Keishi</given-names>
          </name>
          <xref ref-type="aff" rid="af3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Machida</surname>
            <given-names>Hisanori</given-names>
          </name>
          <xref ref-type="aff" rid="af1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="af1"><label>1</label><addr-line>Division of Pulmonary Medicine</addr-line>, <institution>National Hospital Organization Kochi Hospital</institution>, <addr-line>Kochi</addr-line>, <country>Japan</country></aff>
      <aff id="af2"><label>2</label><addr-line>Department of Clinical Investigation</addr-line>, <institution>National Hospital Organization Kochi Hospital</institution>, <addr-line>Kochi</addr-line>, <country>Japan</country></aff>
      <aff id="af3"><label>3</label><addr-line>Division of Pathology</addr-line>, <institution>National Hospital Organization Kochi Hospital</institution>, <addr-line>Kochi</addr-line>, <country>Japan</country></aff>
      <author-notes>
        <corresp><label>Correspondence to</label> Dr Tsutomu Shinohara, <email>shinoharat@kochi2.hosp.go.jp</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>10</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>28</day>
        <month>10</month>
        <year>2016</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
      <volume>2016</volume>
      <elocation-id>bcr2016217555</elocation-id>
      <history>
        <date date-type="accepted">
          <day>15</day>
          <month>10</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>2016 BMJ Publishing Group Ltd</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p>
        </license>
      </permissions>
      <self-uri xlink:title="pdf" xlink:href="bcr-2016-217555.pdf"/>
      <custom-meta-group>
        <custom-meta>
          <meta-name>special-feature</meta-name>
          <meta-value>unlocked</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Description</title>
      <p>A 53-year-old man was referred to our hospital due to malaise with intermittent high fever. Thoracoabdominal CT scan revealed abdominal lymphadenopathy with splenomegaly. Hepatic disorder (aspartate transaminase 47&#x2005;IU/L; alanine transaminase 53&#x2005;IU/L), peripheral blood cytopaenia (red blood cell count 370&#xD7;10<sup>4</sup>/&#x3BC;L; haemoglobin 11.0&#x2005;g/dL; haematocrit 32.9%; platelet count 7.9&#xD7;10<sup>4</sup>/&#x3BC;L), hypertriglyceridaemia (184&#x2005;mg/dL), hyperferritinaemia (4111&#x2005;ng/mL) and an increased serum soluble interleukin-2 receptor level (4450&#x2005;U/mL) were observed. Bone marrow (BM) aspiration showed erythrocyte phagocytosis by macrophages (<xref ref-type="fig" rid="BCR2016217555F1">figure 1</xref>A). However, no atypical cells were detected. Additional BM trephine biopsy was not performed. Pathological examination of a laparoscopic lymph node biopsy revealed Reed-Sternberg cells (<xref ref-type="fig" rid="BCR2016217555F1">figure 1</xref>B), and atypical cells were positive for CD30 but not for CD3, CD20 or CD79a indicating nodular sclerosis Hodgkin lymphoma (HL). A diagnosis of lymphoma-associated haemophagocytic lymphohistiocytosis (LA-HLH) was established. <sup>18</sup>F-fluorodeoxyglucose positron emission tomography (FDG-PET) performed for the staging showed splenic and multiple abdominal lymph node lesions and diffuse accumulation within the bones such as the vertebrae and pelvis (<xref ref-type="fig" rid="BCR2016217555F2">figure 2</xref>A). After four courses of ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine) chemotherapy, FDG-PET showed the disappearance of all abnormal accumulations (<xref ref-type="fig" rid="BCR2016217555F2">figure 2</xref>B). Involved-field radiation therapy for abdominal lesions was sequentially added.</p>
      <fig id="BCR2016217555F1" orientation="portrait" position="float">
        <label>Figure&#xA0;1</label>
        <caption>
          <p>Pathological findings. (A) Bone marrow aspirate smear showing macrophages laden with erythrocytes (arrow). (B) Abdominal lymph node biopsy showing scattered large atypical multinucleated cells (Reed-Sternberg cells; arrows) in prominent small lymphocytes.</p>
        </caption>
        <graphic xlink:href="bcr2016217555f01"/>
      </fig>
      <fig id="BCR2016217555F2" orientation="portrait" position="float">
        <label>Figure&#xA0;2</label>
        <caption>
          <p><sup>18</sup>F-fluorodeoxyglucose positron emission tomography before (A) and after (B) the four courses of ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine) chemotherapy. (A) Splenic (arrow) and multiple abdominal lymph node (arrowheads) lesions and diffuse accumulation within bones such as vertebras and pelvis. (B) Disappearance of all abnormal accumulations.</p>
        </caption>
        <graphic xlink:href="bcr2016217555f02"/>
      </fig>
      <p>Patients with HLH with FDG-PET images indicating multiple lymphadenopathy and/or patchy multiple bone lesions may appear to be LA-HLH with BM involvement (BMI).<xref rid="R1" ref-type="bibr">1</xref> However, in comparison with BM examinations, FDG-PET can frequently show false-positive for the evaluation of BMI in patients with LA-HLH because HLH can induce diffuse hypermetabolism in BM reflecting a systemic cytokine storm.<xref rid="R2" ref-type="bibr">2</xref> Previously, several cases of HLH due to non-HL with diffuse FDG accumulation in BM were reported.<xref rid="R2" ref-type="bibr">2&#x2013;3</xref> Since we performed BM aspiration only without BM trephine biopsy, skeletal and/or BM HL involvement cannot be fully ruled out. However, there is a possibility that HLH due to HL also can induce diffuse hypermetabolism in BM.
<boxed-text position="float" orientation="portrait"><caption><title>Learning points</title></caption><list list-type="bullet"><list-item><p><sup>18</sup>F-fluorodeoxyglucose positron emission tomography (FDG-PET) has become a standard tool for the initial staging and reassessment of Hodgkin lymphoma, which is generally characterised by contiguous lymph node involvement.</p></list-item><list-item><p>Haemophagocytic lymphohistiocytosis, which is the uncontrolled activation of lymphocytes and macrophages caused by various diseases including malignant lymphoma, can induce diffuse hypermetabolism in the bone marrow reflecting a systemic cytokine storm.</p></list-item><list-item><p>Recognition of false-positive findings on FDG-PET is necessary for the evaluation of bone marrow involvement in order to accurately determine the stage of Hodgkin lymphoma, which requires bone marrow examination.</p></list-item></list></boxed-text></p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p><bold>Contributors:</bold> SH drafted the initial manuscript. TS edited and submitted the manuscript. SH, TS and HM were involved in diagnosing and treating the patient. KN performed pathological studies.</p>
      </fn>
      <fn fn-type="COI-statement">
        <p><bold>Competing interests:</bold> None declared.</p>
      </fn>
      <fn>
        <p><bold>Patient consent:</bold> Obtained.</p>
      </fn>
      <fn>
        <p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Wang</surname><given-names>D</given-names></name>, <name><surname>Zhang</surname><given-names>Q</given-names></name><etal/></person-group>
<article-title>The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable</article-title>. <source>J Cancer Res Clin Oncol</source>
<year>2016</year>;<volume>142</volume>:<fpage>859</fpage>&#x2013;<lpage>71</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00432-015-2094-z">doi:10.1007/s00432-015-2094-z</ext-link><pub-id pub-id-type="pmid">26666755</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>YQ</given-names></name>, <name><surname>Ding</surname><given-names>CY</given-names></name>, <name><surname>Xu</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Exploring the role of bone marrow increased FDG uptake on PET/CT in patients with lymphoma-associated hemophagocytic lymphohistiocytosis: a reflection of bone marrow involvement or cytokine storm?</article-title>
<source>Leuk Lymphoma</source>
<year>2015</year>;<volume>19</volume>:<fpage>1</fpage>&#x2013;<lpage>8</lpage>.</mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yiu</surname><given-names>CR</given-names></name>, <name><surname>Kao</surname><given-names>YH</given-names></name>, <name><surname>Phipps</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Positron emission tomography findings in patients with lymphoma-associated haemophagocytic syndrome</article-title>. <source>Singapore Med J</source>
<year>2011</year>;<volume>52</volume>:<fpage>e156</fpage>.<pub-id pub-id-type="pmid">21808950</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
